ibrutinib
janssen,abbvie
['lymphoma', 'mantle,(-dismantle)', 'ibru']
the largest trial to date in mantle cell lymphoma shows that adding the #btkinhibitor ibrutinib to soc treatment improves pfs by 50%. #asco22
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.